In addition, it has recently been shown that the presence of soluble CEACAM1 in the serum reflects tumor burden in pancreatic adenocarcinoma patients [40] and may have prognostic importance in melanoma patients [22]. This evidence concerns the gene CEACAM1 and neoplasm.